Published in Int J Nanomedicine on September 30, 2015
Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex. Int J Nanomedicine (2016) 0.75
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci (2000) 2.55
Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet (2005) 2.25
Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm (2004) 2.10
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm (2004) 1.88
Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J (2007) 1.59
Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm (2007) 1.46
Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res (1994) 1.45
Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm (2009) 1.33
Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm (2007) 1.24
Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res (1990) 1.23
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. Clin Cancer Res (2002) 1.22
Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces (2009) 1.22
Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today (2008) 1.16
Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS PharmSciTech (2008) 1.13
The discovery of ezetimibe: a view from outside the receptor. J Med Chem (2004) 1.09
Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm (2011) 1.06
Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm (2009) 1.06
Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci (2004) 1.04
Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm (2006) 0.97
The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance. Br J Cancer (1990) 0.97
Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces (2012) 0.96
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ther (2001) 0.95
Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. Int J Pharm (2008) 0.92
Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem Photobiol (1994) 0.92
Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine (2014) 0.91
Effects of Cremophor EL on distribution of Taxol to serum lipoproteins. Br J Cancer (1994) 0.89
Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent. Int J Pharm (2013) 0.88
Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm (2010) 0.87
Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm (2005) 0.83
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.81
Comparison of a solid SMEDDS and solid dispersion for enhanced stability and bioavailability of clopidogrel napadisilate. Carbohydr Polym (2014) 0.81
Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv (2010) 0.81
A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution. Arch Pharm Res (2013) 0.81
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL. Blood (1994) 0.80
Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate. Arch Pharm Res (2009) 0.79
Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie (2009) 0.79
Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv (2014) 0.77
Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull (Tokyo) (2011) 0.76
Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym (2015) 0.76
Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Int J Nanomedicine (2015) 0.77
Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int J Nanomedicine (2016) 0.75
Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. Arch Pharm Res (2017) 0.75
Engineered islet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes. FASEB J (2017) 0.75